Picture of Newbury Pharmaceuticals AB logo

NEWBRY — Newbury Pharmaceuticals AB News Story

0.000.00%
se flag iconLast trade - 00:00
Consumer DefensivesHighly SpeculativeMicro CapMomentum Trap

Brief: Newbury Pharmaceuticals Says Dimethyl Fumarate Newbury Approved By Swedish Health Authorities

March 6 (Reuters) - Newbury Pharmaceuticals AB
 NEWBRY.ST :
    * DIMETHYL FUMARATE NEWBURY APPROVED BY SWEDISH HEALTH
AUTHORITIES
    * IS PLEASED TO ANNOUNCE MARKETING AUTHORIZATION (MA) OF
DIMETHYL
FUMARATE NEWBURY 120 & 240 MG HARD CAPSULE IN SWEDEN AS FIRST
COUNTRY IN SCANDINAVIAN REGISTRATION PROCEDURE
    * APPROVALS IN NORWAY, DENMARK ARE EXPECTED TO FOLLOW UPON
FINALIZED NATIONAL REVIEWS

Source text for Eikon:  ID:nMFN8GGS7W 
Further company coverage:  NEWBRY.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Newbury Pharmaceuticals AB

See all news